Literature DB >> 14561100

Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

Sylvie Legrain1, Laurence Girard.   

Abstract

Man and higher primates have adrenals that secrete large amounts of dehydroepiandrosterone (DHEA) [prasterone] and its sulphate (DHEAS) [PB 008]. A remarkable feature of plasma DHEAS levels in humans is their great decrease with aging. Researchers have postulated that this age-related decline of DHEAS levels may explain some of the degenerative changes associated with aging. Moreover, administration of DHEA to laboratory animals has demonstrable beneficial effects such as prevention of diabetes mellitus, obesity, cancer, heart disease and positive immunomodulator effects. However, in rodents DHEA(S) circulating levels are so low that it is impossible to detect any significant age-related decrease. Therefore results from rodent experiments are not relevant to human beings. Three mechanisms of action of DHEA(S) have been identified. DHEA and DHEAS are precursors of testosterone and estradiol, DHEAS is a neurosteroid which modulates neuronal excitability via specific interactions with neurotransmitter receptors and DHEA is an activator of calcium-gated potassium channels. Randomised, placebo-controlled clinical trials which included healthy individuals aged 60 years and over treated with (near) physiological doses of DHEA (50-100 mg/day) have yielded very few positive results. Impact of DHEA replacement treatment was assessed on mood, well being, cognitive and sexual functions, bone mass, body composition, vascular risk factors, immune functions and skin. The major limitations of these trials were their short duration (maximum 1 year) and the low number of study participants involved (maximum 280). Many elderly people in western countries take DHEA without medical supervision. In the US, DHEA is even classified as food supplement. At present there is no scientific evidence to recommend DHEA replacement in the elderly. Further studies are needed to form conclusions about the efficacy and the safety of DHEA replacement in elderly, and to better understand the mechanisms of action of DHEA at the molecular and cellular levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561100     DOI: 10.2165/00002512-200320130-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  142 in total

1.  Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate.

Authors:  R S Rosenfeld; L Hellman; T F Gallagher
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

Review 2.  Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans.

Authors:  O T Wolf; C Kirschbaum
Journal:  Brain Res Brain Res Rev       Date:  1999-11

3.  Dehydroepiandrosterone sulfate and mortality in elderly men and women.

Authors:  D P Trivedi; K T Khaw
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

4.  Role of a novel KCa opener in regulating K+ channels of hypoxic human pulmonary vascular cells.

Authors:  W Peng; J R Hoidal; I S Farrukh
Journal:  Am J Respir Cell Mol Biol       Date:  1999-04       Impact factor: 6.914

5.  Dehydroepiandrosterone replacement in aging humans.

Authors:  M A Flynn; D Weaver-Osterholtz; K L Sharpe-Timms; S Allen; G Krause
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

6.  Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men.

Authors:  Arnold J Kahn; Bernard Halloran; Owen Wolkowitz; Louann Brizendine
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

7.  Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.

Authors:  Michelle A Petri; Robert G Lahita; Ronald F Van Vollenhoven; Joan T Merrill; Michael Schiff; Ellen M Ginzler; Vibeke Strand; Arlene Kunz; Kenneth J Gorelick; Kenneth E Schwartz
Journal:  Arthritis Rheum       Date:  2002-07

8.  Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men.

Authors:  A Z LaCroix; K Yano; D M Reed
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

Review 9.  Steroids as regulators of the mammalian immune response.

Authors:  R A Daynes; B A Araneo; J Hennebold; E Enioutina; H H Mu
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

10.  Effects of dehydroepiandrosterone replacement in elderly men on event-related potentials, memory, and well-being.

Authors:  O T Wolf; E Naumann; D H Hellhammer; C Kirschbaum
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1998-09       Impact factor: 6.053

View more
  6 in total

1.  Effects of positive and negative modulators of the γ-aminobutyric acid A receptor complex on responding under a differential-reinforcement-of-low-rate schedule of reinforcement in rats.

Authors:  Russell J Amato; Peter B Lewis; Hongbo He; Peter J Winsauer
Journal:  Behav Pharmacol       Date:  2010-12       Impact factor: 2.293

2.  Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with age-related macular degeneration.

Authors:  Fatih Ulaş; Mehmet Balbaba; Sedat Özmen; Serdal Çelebi; Ümit Doğan
Journal:  Int Ophthalmol       Date:  2013-02-03       Impact factor: 2.031

Review 3.  Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people.

Authors:  J Grimley Evans; R Malouf; F Huppert; J K van Niekerk
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

4.  Ample Evidence: Dehydroepiandrosterone (DHEA) Conversion into Activated Steroid Hormones Occurs in Adrenal and Ovary in Female Rat.

Authors:  Yingqiao Zhou; Jian Kang; Di Chen; Ningning Han; Haitian Ma
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Long-Term Administration of Dehydroepiandrosterone Accelerates Glucose Catabolism via Activation of PI3K/Akt-PFK-2 Signaling Pathway in Rats Fed a High-Fat Diet.

Authors:  Jian Kang; Chongyang Ge; Lei Yu; Longlong Li; Haitian Ma
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

6.  Dehydroepiandrosterone inhibits cell proliferation and improves viability by regulating S phase and mitochondrial permeability in primary rat Leydig cells.

Authors:  Lin Liu; Dian Wang; Longlong Li; Xiao Ding; Haitian Ma
Journal:  Mol Med Rep       Date:  2016-05-24       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.